Life Sciences Times

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 18, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

UnitedHealthcare CEO Shot Dead in New York City

December 5, 2024

THIS WEEK'S STORIES

Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio

December 18, 2024

Headlamp Health Appoints Veteran Healthcare Technology Leader as Chief Executive Officer and Board Member

December 18, 2024

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

December 18, 2024

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio

EDITOR PICKS

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tasca Therapeutics Launches with $52 Million Series A Financing

UnitedHealthcare CEO Shot Dead in New York City

THIS WEEK'S STORIES

Fresenius Kabi Launches Epinephrine Injection, USP Expanding U.S. Pharma Portfolio

Headlamp Health Appoints Veteran Healthcare Technology Leader as Chief Executive Officer and Board Member

Iron Path Capital Welcomes Ian Thomas as Managing Director – Head of Business Development

POPULAR CATEGORY

ABOUT US

FOLLOW US